Some basic laboratory performancecriteria were studied fortheEastman Kodak glucose and urea nitrogen analyzer. Serum, plasma, urine, and cerebrospinal fluid were tested. Precision, both "within-day" and "between-day," for both analyteswas lessthan 2.2% (CV 
Specimens with negligible total protein concentrations, such as urine and CSF, could not be directly assayed with the human-serum-based calibrators because of viscosity differences that affected the spreading layers of the reagent slides. Therefore, urine and CSF glucose values were measured against aqueous calibrators, which were prepared by adding NBS glucose to a 2.5 g/L benzoic acid solution to give various concentrations. Human serum albumin added to the aqueous calibrators, 0 to 20 g/L, did not affect results. The total protein concentrations in the CSF samples we tested ranged from 0.1
Statistical analysis of the data included analysis of variance and the F-test. Levels of significance for the F-test were derived from standard tables (5).
Results and Discussion

Analytical Variables
Precision.
Patients' serum, oxalate-treated plasma, CSF, and urine pools were tested for "within-day" precision of analysis of urea nitrogen and glucose (Table 1) . Serum and plasma samples results had coefficients of variation (CV) of 1.5% or less for both urea nitrogen and glucose in the normal and abnormal ranges. The maximum CV noted for CSF or urinary glucose was 1.6%. "Between-day" precision was determined with different types of quality-control material; again, each had normal and abnormal urea nitrogen and glucose content. Analyses were conducted over a period of four months and included the introduction of four to six different lots of reagent slides. Human serum-based controls resulted in CV's of 2.1% or less at three different concentrations of urea nitrogen and glucose; aqueous controls resulted in CV's for glucose of 1.8% or less (Table 2 ).
Similar data (not shown) were obtained for two pools of oxalate-treated plasma from patients (CV = 2.3-3.2% for glucose; much greater than the human-based material. We attributed these discrepancies to a matrix effect of the albumin solution on the spreading layer of the reagent slides. Linearity.
Specimens
were serially diluted to determine if linearity between response and concentration was maintained.
The diluents were: (a) de-ionized water for glucose in urine and CSF, and for urea nitrogen in serum, and (b) 7 g/L human serum albumin for glucose in serum. Ilinearity was demonstrated for both analytes ( Figures 1 and 2 ) in all fluids tested over a wide analytical range. Analytical recovery. One aspect of accuracy was determined by adding weighed amounts of NBS glucose or urea to pooled serum, urine, and CSF samples having low concentrations of these. Average recoveries ranging from 94 to 102% (serum), 103 to 106% (urine), and 98 to 112% (CSF) were observed for both the urea and glucose procedures over a wide range of analyte values ( Table   Plasma or serum specimen choice. Matched serum and plasma sample comparisons on the Ektachem for urea nitrogen (Table 4) indicated that values for heparin-and EDTAtreated plasma as well as for lithium-iodoacetate-treated serum were statistically and clinically comparable to those for serum. Values for oxalate-fluoride-treated plasma showed a significant statistical (a = 0.01) and clinically meaningful difference.
A similar study for glucose (Table 5) indicated that although all plasma and the lithium-iodoacetate-treated serum values were statistically different from the serum values, all were clinically acceptable.
Sensitivity.
To determine the minimum amounts of glucose and urea nitrogen that could be detected by the Ektachem, we assayed samples undiluted and serially diluted with 7 g/L human serum albumin (serum) and with de-ionized water (urine and CSF). Each group consisted of 10 replicates. The minimum statistically significant (Student's t-test) amounts of analyte that could be detected were: glucose (serum), 104 mg/L; glucose (urine), 110 mg/L; glucose (CSF), 100 mg/L; and urea nitrogen, 21 mg/L. 
Glucose
Samplesfrom a mixture of hospital subpopulations
were analyzed and the following linear-regression data were obtained: 
I 1Ofl
Test n diluted samples may affect the film chemistry. The human serum albumin was used to keep the serum viscosity constant and, as a diluent for glucose specimens, gave the most acceptable results. Water proved to be the best diluent for urea nitrogen specimens. The Tris diluent yielded high results and was considered not to be acceptable.
Hemolyzed, lipemic, and icteric specimens.
Twenty-five patients' serum samples, varying in degree of hemolysis, were assayed for glucose and urea nitrogen.
Known amounts of NBS glucose and urea were then added to the samples and they were reassayed to determine recoveries. Glucose recoveries ranged from 100-105%, with an average value of 102%.
Urea nitrogen recoveries ranged from 102-110%, with an average value of 106%. Both analytes exhibited a slight increase in recovery with increasing degrees of hemolysis.
In a similar study with 25 patients' samples we examined the effect of lipemia on recovery of glucose and urea. Glucose recoveries ranged from 99-108% (average, 103%). Urea nitrogen recovery values ranged from 100-110% (average, 104%).
We saw no positive relationship between the degree of lipemia and the analytical recovery analyte. The effect of icteric samples on the recovery of glucose and urea was also examined. Sera from 11 patients with bilirubin concentrations ranging from 19 to 196 mg/L were assayed, then NBS glucose and urea were added, to determine recovery. Glucose recoveries ranged from 98-104% (average, 102%). Urea nitrogen recoveries ranged from 96 to 105% (average, 101%). Because the urea nitrogen assay is based on the measurement of ammonia, we examined the effect of endogenously generated ammonia by assaying 10 plasma samples left at room temperature for 0, 4,8, and 24 h. Plasma ammonia had increased three-to eight-fold above the value at zero time by 24 h. However, analysis of the urea nitrogen results by ANOVA and t-test methods (5) demonstrated no statistical differences over the 24-h period.
High protein concentration.
Because both the urea nitrogen and glucose reagent slides involve use of a spreading layer before the serum enters the chemistry layer, we were concerned if there were any possible serum-viscosity effects on that layer. 
Reagent Stability Characteristics
We examined the stability of the reconstituted Ektachem calibrators at three different temperatures for urea nitrogen and glucose over a 28-day period. Calibrator instability for urea nitrogen and glucose occurs when the calibrator remains at 25 #{176}C for 48 h or longer. However, no instability problem was observed if the calibrator was stored at 4 or -12 #{176}C.
Lot-to-lot variation of reagent slides was evaluated over a four-month period with four different glucose reagent lots and three different lots of urea nitrogen reagent. Instrument settings from the initial reagent lot calibration for glucose and urea were entered each day, regardless of reagent slide lots used, and control specimens assayed. Within-lot variation did not exceed 2 SD for any of the controls, which suggests that a single calibration for a given lot of reagent slides may be sufficient. However, values for the controls exceeded 2 SD when a new lot was introduced, making it essential to recalibrate with each new lot of reagent slides. As discussed above, because of matrix viscosity differences, we used aqueous calibrators when urine or CSF samples were assayed. The same unknown specimens that were assayedwith aqueous calibration were also assayed against humanserum-based calibrators. A constant difference was found for results for both CSF and urine glucose. This could allow one to assay all samples with human-serum-based calibrators if the following correction factors are used:
CSF + 18% = final result Urine + 20% = final result
The following data were established when the Ektachem results with aqueous and serum-based calibration were compared with AutoAnalyzer matched results:
CSF: n = 88 Ektachem (aqueous calibration) = 1.14 AutoAnalyzer -51 mgfL r = 0.995 Ektachem (serum-based calibrator with 18% correction factor) = 1.10 AutoAnalyzer In conclusion, we find the Ektachem to be analytically capable in terms of the basic laboratory performance criteria discussed above. Only oxalate-fluoride-treated plasma was deemed unacceptable for urea nitrogen analysis. The instrument is easy to operate, with minimum training required. Its greatest applicability in a large clinical laboratory would appear to be that of an emergency-sample instrument, whereas in a smaller laboratory, it could function either as this or a routine analyzer.
